1[1]Eidelman BH,Abu-Elmagd K,Wilson J et al.Neurologic complications of FK506.Transplant Proc,1991,23:3175
2[2]Appignani B,Bhadelia R,Blacklow S et al.Neuroimaging findings in patients on immunosuppressive therapy:experience with tacrolimus toxicity.Am J Roentagenol,1996,166:683
3[3]Pirsch JD,Miller J,Deierhoi M et al.A comparison of tacrolimus and cyclosporin for immunosuppression after cadaveric renal transplantation.Transplantation,1997,63:977
4[4]Small L,Fukui M,ranblett G et al.Immunosuppression-induced leucoencephalopathy from tacrolimus.Am Neurol,1996,40:575
5[5]De Groen PC,Aksamit AJ,Rakela J et al.Central nervous system toxicity after liver transplantation:the role of cyclosporin and cholesterol.N Engl J Med,1987,317:861
6[6]Shutter LA,Green JP,Newman NJ et al.Cortical blindness and white matter lesions in a patient receiving FK506 after liver transplantation.Neurology,1993,43:2417
7[7]Philippe G,Christine A,Myriam P et al.Tacrolimus(FK506)-induced severe and late encephalopathy in a renal transplant recipient.Nephrol Dial Transplant,1999,14:2489
